A new double blind RCT just published in The Journal of Pain

A friend an colleague emailed me this study that she was on the research team for. I can't wait to share it with you!

A new double blind, placebo controlled RCT on acupuncture for vulvodynia was just published in The Journal of Pain. It is the first multi needle, multi session, double blind acupuncture trial ever conducted for this condition. The lead investigator, Dr. Judith Schlaeger at University of Illinois Chicago, partnered with Dr. Ted Kaptchuk at Harvard's Program in Placebo Studies and Dr. Nobuari Takakura in Japan, whose lab developed the only validated double blind acupuncture needles in existence.

This was not a small study. It took five years to enroll. The methodology was airtight. And the result, on first read, is going to make a lot of skeptics smile.

Then, they're going to read it AGAIN and we'll be the ones smiling!

The trial

89 women with vulvodynia, ages 19 to 62, were randomized to 10 sessions of either real penetrating acupuncture or a skin touch placebo needle that looks, feels, and sounds identical to a real needle. Neither the women nor the acupuncturists knew which they were giving or receiving. Treatment ran twice a week for five weeks.

The acupuncturists were stripped of every contextual healing variable we usually rely on. No music. No aromatherapy. No therapeutic conversation. No reassurance. They followed a 17 step fidelity checklist at every session to make sure the only variable being tested was the needle itself.

The protocol (cause I know you guys love a good point protocol)

Here is the 13 point protocol they used. It was developed in Dr. Schlaeger's earlier pilot work and is grounded in TCM pattern differentiation for vulvar pain.

GV20 at the crown of the head. Anchors the shen, used for chronic disease.

CV2 just above the pubic symphysis. Treats genital itching and burning, a classic point for vulvar conditions.

CV4 three cun below the umbilicus. Reduces spasm of the genitals and tonifies the bao maiand bao luo, the vessels that connect the uterus, kidneys and heart.

KD11 bilaterally just lateral to CV2. Treats genital pain directly. Local kidney meridian point on the pelvis.

ST30 bilaterally on the inguinal crease. Treats swelling and pain of the genitals. A sea of qipoint of the stomach channel where chong mai originates.

LI4 bilaterally in the web between thumb and index finger. Treats spasm of the genitals through its distal command relationship and its powerful qi moving function.

SP6 bilaterally four fingers above the inner ankle. Relaxes the genitals, regulates the lower jiao, crossing point of three yin channels of the leg.

LR3 bilaterally on the dorsum of the foot. Treats genital pain through the liver channel, which wraps the external genitalia in its trajectory.

13 needles. 45 minute retention. Perpendicular insertion using tapping in method. No intentional de qi. Twice a week. Five weeks.

The headline finding (and why it is not the real finding)

At the end of 10 sessions, 58% of the real acupuncture group and 57% of the placebo group met the criteria for clinically meaningful improvement. The two groups were statistically indistinguishable on average pain intensity, dyspareunia, and sexual function.

This is the moment the skeptics will screenshot. Hold on.

The investigators then did something most trials skip. They followed every single responder for 12 weeks after treatment ended and asked one question: how long does the relief last.

The real finding

At 28 days post treatment, half of the placebo responders had already returned to their baseline pain.

In the real acupuncture group, only 1 woman had returned to baseline in the same window.

Across the full 12 weeks of follow up, the placebo responders had a 2.7 times higher rate of returning to baseline pain compared to the real acupuncture responders. That is statistically significant. That is also clinically obvious. Placebo did something. Then it stopped. Real acupuncture did something. And the body held it.

This is the part of the story that matters.

Why this matters for our clients

Vulvodynia affects 7% of American women. 70% of them report severe pain, greater than 6 out of 10. 60% use alcohol to cope. 43% combine alcohol with analgesics, including opioids. Women with vulvodynia experience higher rates of physical disability, depression, and suicidal ideation.

The conventional treatment shelf for vulvodynia is nearly empty. Topical lidocaine. Tricyclics. Pelvic floor PT. Vestibulectomy as a last resort. Most women I see in clinic have tried all of it. By the time they walk through the acupuncture door, they have usually been suffering for years.

What this study tells us is that we have a 13 point protocol with measurable durability. 12 weeks of sustained pain reduction. Zero adverse events across 89 women. A treatment they can come back to as the effect wanes.

What this study does not prove, and why it still matters

This study did not prove that acupuncture beats placebo at the moment treatment ends. The investigators are honest about this. The placebo response was likely inflated because the women in the trial were a desperate population, with few effective options, walking in with high expectation and high hope. The placebo needle is also known to produce a real, short lived physiological response of its own.

What the study does prove is methodological and durable. This is the first ever double blind, multi needle, multi session RCT for vulvodynia. The 13 point protocol works in responders. And the durability gap between real and placebo is exactly what we would expect to see if penetrating acupuncture is doing something structural that placebo cannot do.

The question I am sitting with

The question for our profession is no longer whether acupuncture works for vulvodynia. We have the evidence. We have a replicable protocol. We have safety data.

The question is who is trained to deliver it.

Most acupuncturists never receive pelvic specific training in school. Most do not know how to assess for provoked vestibulodynia versus generalized vulvodynia, or how to safely examine and treat the external genitalia within scope.

This is the gap we built Pelvic Acu to close.

If this study moves you the way it moved me, I want to invite you in.

Be the acu who knows how.

References
Schlaeger JM, Steffen AD, Takakura N, Kobak WH, Takayama M, Yajima H, Suarez ML, Meinel M, Burke LA, Pauls HA, Yao Y, Sullivan KM, Glayzer JE, Foster DC, Kaptchuk TJ, Wilkie DJ. Long lasting effect of penetrating acupuncture among responders: Double blind RCT of acupuncture for vulvodynia. J Pain. 2026;38:105584. DOI: 10.1016/j.jpain.2025.105584.